{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:14:22Z","timestamp":1794978862065,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01230-1","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:58:47Z","timestamp":1773176327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-815X","authenticated-orcid":false,"given":"Jinhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mack","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Keire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-0813","authenticated-orcid":false,"given":"Patrick J.","family":"Faustino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"1230_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105709","volume":"153","author":"RH Heflich","year":"2024","unstructured":"Heflich RH, Bishop ME, Mittelstaedt RA, et al. Optimizing the detection of N-nitrosamine mutagenicity in the Ames test. Regul Toxicol Pharmacol. 2024;153:105709. https:\/\/doi.org\/10.1016\/j.yrtph.2024.105709.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1230_CR2","unstructured":"Updated Information | Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs) Guidance for Industry. 2025; FDA. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cder-nitrosamine-impurity-acceptable-intake-limits."},{"key":"1230_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113582","volume":"191","author":"YM Alshehri","year":"2020","unstructured":"Alshehri YM, Alghamdi TS, Aldawsari FS. Hs-spme-gc-ms as an alternative method for NDMA analysis in ranitidine products. J Pharm Biomed Anal. 2020;191:113582. https:\/\/doi.org\/10.1016\/j.jpba.2020.113582.","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"1230_CR4","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.xphs.2023.07.022","volume":"112","author":"J Yang","year":"2023","unstructured":"Yang J, Kakarla R, Marzan T, et al. Performance characteristics of mass spectrometry-based analytical procedures for quantitation of nitrosamines in pharmaceuticals: insights from an inter-laboratory study. J Pharm Sci. 2023;112(10):2685\u201395. https:\/\/doi.org\/10.1016\/j.xphs.2023.07.022.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1230_CR5","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-022-00702-4","volume":"24","author":"DA Keire","year":"2022","unstructured":"Keire DA, Bream R, Wollein U, et al. International regulatory collaboration on the analysis of nitrosamines in Metformin-containing medicines. AAPS J. 2022;24(3):56. https:\/\/doi.org\/10.1208\/s12248-022-00702-4.","journal-title":"AAPS J"},{"issue":"9","key":"1230_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4155\/bio-2020-0055","volume":"12","author":"L Yuan","year":"2020","unstructured":"Yuan L, Sophia Xu X, Ji QC. Challenges and recommendations in developing LC-MS\/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites. Bioanalysis. 2020;12(9):615\u201324. https:\/\/doi.org\/10.4155\/bio-2020-0055.","journal-title":"Bioanalysis"},{"issue":"12","key":"1230_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.9519","volume":"37","author":"L Chen","year":"2023","unstructured":"Chen L, Pan H, Zhai G, et al. Widespread occurrence of in-source fragmentation in the analysis of natural compounds by liquid chromatography-electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 2023;37(12):e9519. https:\/\/doi.org\/10.1002\/rcm.9519.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1230_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.465399","volume":"1736","author":"J Zheng","year":"2024","unstructured":"Zheng J, Radich CL, Gong X, Liang X, Mowery MD. A practical HPLC-MS method for the analysis of nitrosamine drug substance related impurities using an inexpensive single quadrupole mass spectrometer. J Chromatogr A. 2024;1736:465399. https:\/\/doi.org\/10.1016\/j.chroma.2024.465399.","journal-title":"J Chromatogr A"},{"key":"1230_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2024.126752","volume":"282","author":"T Planinsek Parfant","year":"2025","unstructured":"Planinsek Parfant T, Roskar R. A comprehensive approach for N-nitrosamine determination in pharmaceuticals using a novel HILIC-based solid phase extraction and LC-HRMS. Talanta. 2025;282:126752. https:\/\/doi.org\/10.1016\/j.talanta.2024.126752.","journal-title":"Talanta"},{"issue":"10","key":"1230_CR10","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1016\/j.xphs.2024.07.022","volume":"113","author":"J Zhang","year":"2024","unstructured":"Zhang J, Raghavachari R, Kirkpatrick DC, Keire DA, Xu X, Faustino PJ. Analytical procedure development and proposed established conditions: a case study of a mass spectrometry based NDSRI analytical procedure. J Pharm Sci. 2024;113(10):3028\u201333. https:\/\/doi.org\/10.1016\/j.xphs.2024.07.022.","journal-title":"J Pharm Sci"},{"key":"1230_CR11","unstructured":"Validation of Analytical Procedures: Text and Methdology Q2(R1). 2005; ICH. https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29%20Guideline.pdf."},{"key":"1230_CR12","unstructured":"Validation of Analytical Procedures Q2(R2). 2023;ICH. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2%28R2%29_Guideline_2023_1130.pdf. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2%28R2%29_Guideline_2023_1130.pdf"},{"key":"1230_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijms.2025.117411","volume":"509","author":"M Shih","year":"2025","unstructured":"Shih M, Faustino PJ, O\u2019Connor TF, Zhang JH. Influence of mass spectrometry source settings on native protein ion mobility mass spectrometry measurements. Int J Mass Spectrom. 2025;509:ARTN 117411. https:\/\/doi.org\/10.1016\/j.ijms.2025.117411.","journal-title":"Int J Mass Spectrom"},{"key":"1230_CR14","unstructured":"ICH Q12 - Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Training Material Module 3 \u2013 Established conditions (ECs). 2021; ICH. https:\/\/www.ich.org\/page\/quality-guidelines.\u00a0"},{"key":"1230_CR15","unstructured":"ICH Q2(R2)\/Q14 Step 4 Presentation. 2023; ICH.\u00a0https:\/\/database.ich.org\/sites\/default\/files\/Q2_Q14%20ICH_Step_4_Presentation_2023_1106_0_1.pdf.\u00a0"},{"issue":"2","key":"1230_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jms.4679","volume":"56","author":"JT Davidson","year":"2021","unstructured":"Davidson JT, Sasiene ZJ, Jackson GP. Comparison of in-source collision-induced dissociation and beam-type collision-induced dissociation of emerging synthetic drugs using a high-resolution quadrupole time-of-flight mass spectrometer. J Mass Spectrom. 2021;56(2):e4679. https:\/\/doi.org\/10.1002\/jms.4679.","journal-title":"J Mass Spectrom"},{"issue":"21","key":"1230_CR17","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1021\/ac202017c","volume":"83","author":"W Jian","year":"2011","unstructured":"Jian W, Romm MV, Edom RW, Miller VP, LaMarr WA, Weng N. Evaluation of a high-throughput online solid phase extraction-tandem mass spectrometry system for in vivo bioanalytical studies. Anal Chem. 2011;83(21):8259\u201366. https:\/\/doi.org\/10.1021\/ac202017c.","journal-title":"Anal Chem"},{"key":"1230_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28093765","author":"J Xie","year":"2023","unstructured":"Xie J, Guo Y, Ma Y, et al. Spontaneous in-source fragmentation reaction mechanism and highly sensitive analysis of dicofol by electrospray ionization mass spectrometry. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28093765.","journal-title":"Molecules"},{"issue":"2","key":"1230_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1021\/jasms.9b00061","volume":"31","author":"A Criscuolo","year":"2020","unstructured":"Criscuolo A, Zeller M, Fedorova M. Evaluation of lipid in-source fragmentation on different Orbitrap-based mass spectrometers. J Am Soc Mass Spectrom. 2020;31(2):463\u20136. https:\/\/doi.org\/10.1021\/jasms.9b00061.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"13","key":"1230_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.10033","volume":"39","author":"MA Glenister","year":"2025","unstructured":"Glenister MA, Mistarz U, Cook K, Stephenson JL, Dickman MJ. Optimisation of heated electrospray ionisation parameters to minimise in-source generated impurities in the analysis of oligonucleotide therapeutics. Rapid Commun Mass Spectrom. 2025;39(13):e10033. https:\/\/doi.org\/10.1002\/rcm.10033.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"3","key":"1230_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/19420862.2018.1433973","volume":"10","author":"OV Friese","year":"2018","unstructured":"Friese OV, Smith JN, Brown PW, Rouse JC. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry. MAbs. 2018;10(3):335\u201345. https:\/\/doi.org\/10.1080\/19420862.2018.1433973.","journal-title":"MAbs"},{"key":"1230_CR22","unstructured":"Analytical Procedure Development Q14. 2023; ICH. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1116.pdf. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1116.pdf"},{"key":"1230_CR23","unstructured":"Keire D. The Future is Now: ICH Q14: Analytical Procedure Development ICH Q2(R2): Validation of Analytical Procedures. 2022:"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01230-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:35:13Z","timestamp":1774460113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01230-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01230-1","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no personal or financial conflict of interest and have not entered into any agreement that could interfere with our access to the data on the research or on our ability to analyze the data independently, and to prepare and publish manuscripts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"69"}}